Sunshine Biopharma Inc.

30/08/2011 | Press release | Archived content

CLEARANCE OF SUNSHINE BIOPHARMA’S ANTI CANCER COMPOUND, ADVA 27A, DOES NOT INVOLVE A TOXIC INTERMEDIATE